Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
The Effect of Continuing or Discontinuing ACE-I/ARBs Therapy on the Incidence of Contrast-induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Coronary Angiography; a Randomized Controlled Trial
Sponsor: An-Najah National University
A NA clinical study on Chronic Kidney Diseases and Contrast-induced Nephropathy, this trial is ongoing. The trial is conducted by An-Najah National University and has accumulated 6 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Jun 2025 — Sep 2025 [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Jun 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Apr 2022 — Jul 2023 [monthly]
Recruiting NA
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- An-Najah National University
For direct contact, visit the study record on ClinicalTrials.gov .